Abiopharma

News list

Director HOLTH KRISTIN 🟡 adjusted position in 2.4K shares (2 derivative) of Noble Corp plc (NE) Transaction Date: Apr 29, 2026 | Filing ID: 000119

Full text

News bot May 1, 2026, 11:49 p.m.
🔍 HOLTH KRISTIN (Director)

Company: Noble Corp plc (NE)

Report Date: 2026-04-29
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 3,649
- Total shares sold: 6,082
Detailed Transactions and Holdings:
- Acquired 3,649 shares of A Ordinary Shares (Direct)
  Date: 2026-04-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 15,810.00 | transaction_form_type: 4
- Sold 3,649 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,433.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
- Sold 2,433 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-29 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F3, F2, F2
Footnotes:
- F1: Upon vesting, each restricted stock unit (RSU) become payable 60% in A Ordinary Shares on a 1 for 1 basis and 40% in cash based on the cash value of the underlying A Ordinary Shares on the date of vesting.
- F2: These RSUs vested in accordance with the accelerated vesting provisions of the RSU award agreement.
- F3: RSUs settled in cash at $50.95 for an aggregate amount of $123,961.35.